BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28317038)

  • 21. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
    Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
    CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
    Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trace amine-associated receptor 1 modulates dopaminergic activity.
    Lindemann L; Meyer CA; Jeanneau K; Bradaia A; Ozmen L; Bluethmann H; Bettler B; Wettstein JG; Borroni E; Moreau JL; Hoener MC
    J Pharmacol Exp Ther; 2008 Mar; 324(3):948-56. PubMed ID: 18083911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum.
    Harsing LG; Knoll J; Miklya I
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
    J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
    Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.
    Blum K; Febo M; Badgaiyan RD
    Austin Addict Sci; 2016; 1(2):. PubMed ID: 27840857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.
    Blum K; Thanos PK; Oscar-Berman M; Febo M; Baron D; Badgaiyan RD; Gardner E; Demetrovics Z; Fahlke C; Haberstick BC; Dushaj K; Gold MS
    J Reward Defic Syndr; 2015; 1(3):95-104. PubMed ID: 27398406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D
    Asif-Malik A; Hoener MC; Canales JJ
    Sci Rep; 2017 Oct; 7(1):13901. PubMed ID: 29066851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of trace amine-associated receptor 1 (TAAR1) transiently reduces alcohol drinking in socially housed mice.
    Frycz BA; Nowicka K; Konopka A; Hoener MC; Bulska E; Kaczmarek L; Stefaniuk M
    Addict Biol; 2023 Jul; 28(7):e13285. PubMed ID: 37369127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor.
    Espinoza S; Salahpour A; Masri B; Sotnikova TD; Messa M; Barak LS; Caron MG; Gainetdinov RR
    Mol Pharmacol; 2011 Sep; 80(3):416-25. PubMed ID: 21670104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
    Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward.
    Moore CF; Sabino V; Cottone P
    Front Pharmacol; 2018; 9():129. PubMed ID: 29535626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine.
    Schwartz MD; Palmerston JB; Lee DL; Hoener MC; Kilduff TS
    Front Pharmacol; 2018; 9():35. PubMed ID: 29456505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research progress on the immunomodulatory effects and mechanisms of trace amine-associated receptor 1].
    Zhang XQ; Li JT; Si TM; Su YA
    Sheng Li Xue Bao; 2023 Apr; 75(2):248-254. PubMed ID: 37089099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Case for TAAR1 as a Modulator of Central Nervous System Function.
    Rutigliano G; Accorroni A; Zucchi R
    Front Pharmacol; 2017; 8():987. PubMed ID: 29375386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
    Pei Y; Mortas P; Hoener MC; Canales JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.